110 related articles for article (PubMed ID: 15564883)
1. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.
Shi JY; Shi ZZ; Zhang SJ; Zhu YM; Gu BW; Li G; Bai XT; Gao XD; Hu J; Jin W; Huang W; Chen Z; Chen SJ
Pharmacogenetics; 2004 Nov; 14(11):759-68. PubMed ID: 15564883
[TBL] [Abstract][Full Text] [Related]
2. The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine.
Lee HW; Lee SH; Lee MG; Ahn SH; Chang HY; Han KH
J Med Virol; 2016 May; 88(5):820-7. PubMed ID: 26400223
[TBL] [Abstract][Full Text] [Related]
3. High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia.
Veuger MJ; Honders MW; Landegent JE; Willemze R; Barge RM
Blood; 2000 Aug; 96(4):1517-24. PubMed ID: 10942400
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
[TBL] [Abstract][Full Text] [Related]
5. Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia.
Veuger MJ; Honders MW; Willemze R; Barge RM
Eur J Haematol; 2002 Sep; 69(3):171-8. PubMed ID: 12406011
[TBL] [Abstract][Full Text] [Related]
6. Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells.
Veuger MJ; Heemskerk MH; Honders MW; Willemze R; Barge RM
Blood; 2002 Feb; 99(4):1373-80. PubMed ID: 11830489
[TBL] [Abstract][Full Text] [Related]
7. A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells.
Veuger MJ; Honders MW; Landegent JE; Willemze R; Barge RM
Leukemia; 2000 Sep; 14(9):1678-84. PubMed ID: 10995016
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
Lamba JK; Crews K; Pounds S; Schuetz EG; Gresham J; Gandhi V; Plunkett W; Rubnitz J; Ribeiro R
J Pharmacol Exp Ther; 2007 Dec; 323(3):935-45. PubMed ID: 17855478
[TBL] [Abstract][Full Text] [Related]
9. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
Galmarini CM; Thomas X; Graham K; El Jafaari A; Cros E; Jordheim L; Mackey JR; Dumontet C
Br J Haematol; 2003 Jul; 122(1):53-60. PubMed ID: 12823345
[TBL] [Abstract][Full Text] [Related]
10. Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.
Joerger M; Bosch TM; Doodeman VD; Beijnen JH; Smits PH; Schellens JH
Eur J Clin Pharmacol; 2006 Aug; 62(8):681-4. PubMed ID: 16799820
[TBL] [Abstract][Full Text] [Related]
11. Multicapillary electrophoresis analysis of single-nucleotide sequence variations in the deoxycytidine kinase gene.
Szantai E; Ronai Z; Sasvari-Szekely M; Bonn G; Guttman A
Clin Chem; 2006 Sep; 52(9):1756-62. PubMed ID: 16858072
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M
Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143
[TBL] [Abstract][Full Text] [Related]
13. Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
Rivero A; Rapado I; Tomás JF; Montalbán C; de Oña R; Paz-Carreira J; Canales M; Martínez R; Sánchez-Godoy P; de Sevilla AF; de la Serna J; Martínez-López J
Leuk Res; 2011 Apr; 35(4):431-7. PubMed ID: 21030078
[TBL] [Abstract][Full Text] [Related]
14. In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene.
Stegmann AP; Honders MW; Hagemeijer A; Hoebee B; Willemze R; Landegent JE
Ann Hematol; 1995 Jul; 71(1):41-7. PubMed ID: 7543292
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.
Flasshove M; Strumberg D; Ayscue L; Mitchell BS; Tirier C; Heit W; Seeber S; Schütte J
Leukemia; 1994 May; 8(5):780-5. PubMed ID: 7514246
[TBL] [Abstract][Full Text] [Related]
16. Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.
van der Wilt CL; Kroep JR; Loves WJ; Rots MG; Van Groeningen CJ; Kaspers GJ; Peters GJ
Eur J Cancer; 2003 Mar; 39(5):691-7. PubMed ID: 12628850
[TBL] [Abstract][Full Text] [Related]
17. The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity.
Braess J; Voss S; Jahns-Streubel G; Schoch C; Haferlach T; Kern W; Keye S; Schleyer E; Hiddemann W
Br J Haematol; 2000 Jul; 110(1):170-9. PubMed ID: 10930995
[TBL] [Abstract][Full Text] [Related]
18. Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity.
Stegmann AP; Honders WH; Willemze R; Ruiz van Haperen VW; Landegent JE
Blood; 1995 Mar; 85(5):1188-94. PubMed ID: 7532033
[TBL] [Abstract][Full Text] [Related]
19. Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase.
Falk IJ; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
Am J Hematol; 2013 Dec; 88(12):1001-6. PubMed ID: 23873772
[TBL] [Abstract][Full Text] [Related]
20. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
